P906: ixazomib, daratumumab and low dose dexamethasone in frail patients with newly diagnosed multiple myeloma (ndmm): results of the maintenance treatment of the phase ii hovon 143 study

K. Groen, M. Seefat,K. Nasserinejad,C. A. Stege,E. van der Spek, Y. M. Bilgin,A. Kentos,M. Sohne, R. J. van Kampen,I. Ludwig,N. Thielen, N. Durdu-Rayman, N. C. de Graauw,N. W. van de Donk, E. G. de Waal,M.-C. Vekemans, G. J. Timmers,M. van der Klift,S. Soechit,P. A. Geerts, M. H. Silbermann,M. Oosterveld, I. Nijhof,P. Sonneveld,S. K. Klein,M.-D. Levin,S. Zweegman

HemaSphere(2022)

引用 0|浏览10
暂无评分
关键词
multiple myeloma,ixazomib,low dose dexamethasone,daratumumab,frail patients
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要